S100B and depressive symptom measurement: While there are no reported genetic polymorphisms of S100B in depression [36], this molecule has been linked to the development of depressive symptoms in subjects with comorbid somatic illnesses, such as end-stage renal diseases and myocardial infarction [37,38].